Crizocent Crizotinib is an anti-cancer medication that works by kinase inhibition and prevents the growth and metastasis of cancerous cells in the human body. Crizocent 250 mg is used for the treatment of cases who have locally advanced or metastatic non-small cell lung cancer (NSCLC).
Specification/Additional Details
- 60 Capsules
- INCEPTA
- Crizotinib 250 Mg
- Incepta
- Capsule
Reviews
There are no reviews yet.